Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Heidegger

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
The American Journal of Pathology|October 9, 2012
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205Martin Puhr, Julia Hoefer, Georg Schäfer, et al.
Urology|December 4, 2013
Gender-related fetal development of the internal urethral sphincterJosef Oswald, Isabel Heidegger, Eberhard Steiner, et al.
Oncotarget|December 5, 2014
PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cellsMartin Puhr, Julia Hoefer, Hannes Neuwirt, et al.
World Journal of Urology|May 8, 2019
Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survivalAndrea Katharina Lindner, Gert Schachtner, Eberhard Steiner, et al.
European Urology Open Science|December 24, 2025
Integration of Darolutamide in the Treatment Landscape for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis of Efficacy and SafetyFelix Melchior, Magdalena Koett, Felix Keller, et al.
Clinical Genitourinary Cancer|May 9, 2025
The Clinical Trajectory of Prostate Cancer Patients Harboring Rare Histological Subtypes-A Retrospective Cohort TrialNastasiia Artamonova, Leon Galleé, Hannes Neuwirt, et al.
Cancer Biology & Therapy|August 2, 2018
Antidiabetic drugs influence molecular mechanisms in prostate cancerAndreas Pircher, Martin Zieher, Andrea Eigentler, et al.
STAR Protocols|December 11, 2024
Profiling low-mRNA content cells in complex human tissues using BD Rhapsody single-cell analysisAlexandra Scheiber, Manuel Trebo, Annabella Pittl, et al.
European Urology Oncology|May 1, 2025
Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic ProfilesMaria Frantzi, Piotr Tymoszuk, Stefan Salcher, et al.
World Journal of Urology|July 16, 2022
Validation of diagnostic nomograms based on CE-MS urinary biomarkers to detect clinically significant prostate cancerMaria Frantzi, Isabel Heidegger, Marie C Roesch, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
The American Journal of Pathology|October 9, 2012
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205Martin Puhr, Julia Hoefer, Georg Schäfer, et al.
Urology|December 4, 2013
Gender-related fetal development of the internal urethral sphincterJosef Oswald, Isabel Heidegger, Eberhard Steiner, et al.
Oncotarget|December 5, 2014
PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cellsMartin Puhr, Julia Hoefer, Hannes Neuwirt, et al.
World Journal of Urology|May 8, 2019
Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survivalAndrea Katharina Lindner, Gert Schachtner, Eberhard Steiner, et al.
European Urology Open Science|December 24, 2025
Integration of Darolutamide in the Treatment Landscape for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis of Efficacy and SafetyFelix Melchior, Magdalena Koett, Felix Keller, et al.
Clinical Genitourinary Cancer|May 9, 2025
The Clinical Trajectory of Prostate Cancer Patients Harboring Rare Histological Subtypes-A Retrospective Cohort TrialNastasiia Artamonova, Leon Galleé, Hannes Neuwirt, et al.
Cancer Biology & Therapy|August 2, 2018
Antidiabetic drugs influence molecular mechanisms in prostate cancerAndreas Pircher, Martin Zieher, Andrea Eigentler, et al.
STAR Protocols|December 11, 2024
Profiling low-mRNA content cells in complex human tissues using BD Rhapsody single-cell analysisAlexandra Scheiber, Manuel Trebo, Annabella Pittl, et al.
European Urology Oncology|May 1, 2025
Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic ProfilesMaria Frantzi, Piotr Tymoszuk, Stefan Salcher, et al.
World Journal of Urology|July 16, 2022
Validation of diagnostic nomograms based on CE-MS urinary biomarkers to detect clinically significant prostate cancerMaria Frantzi, Isabel Heidegger, Marie C Roesch, et al.
Pageof 16